Regenerative Medical Solutions Company
Regenerative Medical Solutions is a developer of regenerative medical products used to treat diabetes. The company offers ProgenMix, a media formulation that generates pancreatic progenitor cells and endocrine cell types; works with multiple human ESC and iPSC lines; and operates as a platform for drug testing and assay development. It also provides consulting services; and engages in developing treatments and applications for diabetes patients. The company’s ProgenMix is used in various applications ranging from scientific research to test the potential toxicity of candidate drugs. Regenerative Medical Solutions was incorporated in 2010 and is based in Chicago, Illinois
Technology:
Drug Delivery
Industry:
Regenerative Medicine
Headquarters:
Chicago, Illinois, United States
Zip:
1-10
Founded Date:
2010-01-01
Employees Number:
1-10
Investors Number:
1475000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Undisclosed
Last Funding Type:
info@regenmedsolutions.com
Register and Claim Ownership